Jul 30
|
New Data Presented at AAIC Demonstrates Investigational LEQEMBI® (lecanemab-irmb) 360 mg Subcutaneous Maintenance Dosing Could Offer a New Option for Ongoing Treatment of Early Alzheimer's Disease
|
Jul 30
|
Early Alzheimer's Patients Continue to Benefit from Four Years of LEQEMBI® (lecanemab-irmb) Therapy New Clinical Data Presented at AAIC
|
Jul 30
|
Eli Lilly eyes SoC status as Jaypirca proves superior to Imbruvica in CLL/SLL
|
Jul 30
|
Biogen Earnings: What To Look For From BIIB
|
Jul 28
|
Biotech stocks dip as Trump administration mulls patent fee overhaul
|
Jul 28
|
Biogen Gears Up to Report Q2 Earnings: Here's What to Expect
|
Jul 28
|
BioMarin Pharmaceutical (BMRN) Reports Next Week: Wall Street Expects Earnings Growth
|
Jul 25
|
ZURZUVAE® (zuranolone) Receives Positive Opinion from CHMP for the Treatment of Women with Postpartum Depression
|
Jul 23
|
Amyotrophic Lateral Sclerosis (ALS) Market Forecast Report 2025-2034 | Advancements in Therapeutics and Approved Medications Such as Riluzole, Edaravone, and Nuedexta Drive Growth
|
Jul 22
|
Biogen to invest further $2bn in North Carolina’s Research Triangle Park
|
Jul 21
|
Biogen to Highlight Scientific Progress Across Alzheimer’s Disease at the Alzheimer’s Association International Conference 2025
|
Jul 21
|
Biogen Inc. (BIIB) Partners with Stoke Therapeutics to Tackle Dravet Syndrome
|
Jul 21
|
Biogen (BIIB) Stock Trades Down, Here Is Why
|
Jul 21
|
Biogen beefs up North Carolina manufacturing ahead of potential Trump tariff
|
Jul 21
|
S&P 500, Nasdaq Scale New Highs in Broad-Based Rally
|
Jul 21
|
Target downgraded, Dollar Tree upgraded: Wall Street's top analyst calls
|
Jul 21
|
Biogen beefs up North Carolina manufacturing ahead of potential drug tariff storm
|
Jul 21
|
Biogen Announces $2 Billion Manufacturing Investment in North Carolina’s Research Triangle Park in Conjunction with its 30th Anniversary
|
Jul 18
|
Repligen, Bruker, Fortrea, Azenta, and Biogen Stocks Trade Down, What You Need To Know
|
Jul 18
|
Here's What to Expect From Biogen's Next Earnings Report
|